Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination Dear Editor, The novel Coronavirus Disease 2019 (COVID-19) pandemic continues to harm health, economics, education, sociocultural and political terms worldwide. CLL patients hence present with mild or no symptoms, negative RT-PCR, and localized endothelial damage to the acral sites. 4 CLL patients are liable to relapse at new contact with SARS-CoV-2.4 With deployment of inactivated SARS-CoV-2 vaccine, it is aimed to create an optimum immunological response by giving attenuated particles of the virus.[Extracted from the article]

Copyright of International Journal of Dermatology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. Copyright applies to all Abstracts.